Barclays PLC Decreases Holdings in Genpact Limited (NYSE:G)

Barclays PLC trimmed its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 35.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 49,504 shares of the business services provider's stock after selling 27,232 shares during the period. Barclays PLC's holdings in Genpact were worth $1,942,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Jensen Investment Management Inc. grew its holdings in Genpact by 6.4% during the third quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider's stock valued at $7,449,000 after purchasing an additional 11,410 shares during the period. Stifel Financial Corp purchased a new position in shares of Genpact during the 3rd quarter valued at $1,197,000. Vanguard Personalized Indexing Management LLC grew its stake in shares of Genpact by 53.1% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 49,134 shares of the business services provider's stock worth $1,580,000 after acquiring an additional 17,034 shares during the period. Access Investment Management LLC increased its holdings in Genpact by 44.0% in the 3rd quarter. Access Investment Management LLC now owns 212,875 shares of the business services provider's stock worth $8,347,000 after acquiring an additional 65,070 shares during the last quarter. Finally, Stephens Inc. AR bought a new stake in Genpact in the 3rd quarter valued at about $511,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

Genpact Trading Down 0.5 %

Shares of G stock traded down $0.23 during mid-day trading on Friday, reaching $42.91. The stock had a trading volume of 585,667 shares, compared to its average volume of 1,359,983. The firm has a market capitalization of $7.57 billion, a PE ratio of 11.79, a price-to-earnings-growth ratio of 1.56 and a beta of 1.18. The stock's 50-day moving average price is $43.05 and its two-hundred day moving average price is $38.36. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $47.98.

Genpact Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 23rd. Investors of record on Monday, December 9th were given a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a dividend yield of 1.42%. The ex-dividend date was Monday, December 9th. Genpact's dividend payout ratio is currently 16.76%.

Insider Buying and Selling

In related news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $44.60, for a total value of $606,560.00. Following the sale, the chief executive officer now owns 267,404 shares in the company, valued at $11,926,218.40. This represents a 4.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders sold a total of 23,058 shares of company stock valued at $1,044,715 over the last three months. Corporate insiders own 2.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on G shares. Needham & Company LLC raised their price target on Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a report on Monday, November 11th. TD Cowen lifted their target price on Genpact from $40.00 to $45.00 and gave the company a "hold" rating in a report on Friday, November 8th. JPMorgan Chase & Co. increased their price target on shares of Genpact from $35.00 to $43.00 and gave the stock a "neutral" rating in a report on Friday, September 6th. Robert W. Baird boosted their price objective on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research note on Friday, November 8th. Finally, Jefferies Financial Group upped their target price on shares of Genpact from $35.00 to $40.00 and gave the stock a "hold" rating in a report on Monday, September 9th. Eight investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Genpact presently has a consensus rating of "Hold" and a consensus target price of $42.33.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.